Examining valganciclovir prophylaxis duration among high‐risk donor seropositive/recipient seronegative heart transplant recipients in a larger cohort
- 2 February 2021
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4), e13581
- https://doi.org/10.1111/tid.13581
Abstract
Click on the article title to read more.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (K23 HL143050, HHSN272201600019C, HHSN272201600016C, HHSN272201100041C, T32 AI118690‐03)
This publication has 1 reference indexed in Scilit: